Search Results
Facet (Page)
Refine Your Search
Audiences
Content Formats
Sections
Careers and Training
The Health Disparities Unit (HDU) in the Social and Behavioral Research Branch (SBRB) of the National Human Genome Research Institute (NHGRI) is recruiting a postdoctoral fellow interested in the study of the intersection of genomics, social determinants of health and health inequities.
Event
The Genomics and Health Disparities Lecture Series was formed to enhance opportunities for dialogue about how innovations in genomics research and technology can impact health disparities. Topics will range from basic science to translational research.
… and the Office of Minority Health at the Food and Drug Administration. Request an Accommodation … Virtual: Zoom …
News Release
NHGRI researchers have identified a genomic signature for some aggressive prostate tumors, which may help healthcare providers pinpoint treatment options.
… - and prostate tumors - might respond to PARP inhibitor therapy. The research team is now exploring the molecular …
Educational Resources
Personalized medicine is an emerging practice of medicine that uses an individual's genetic profile to guide decisions made in regard to the prevention, diagnosis, and treatment of disease.
… profile can help doctors select the proper medication or therapy and administer it using the proper dose or regimen. …
Staff
Dr. Ellen Sidransky is a pediatrician and clinical geneticist in the Medical Genetics Branch at the National Human Genome Research Institute.
… and the development of small molecule chaperones as therapy for Gaucher disease and potentially parkinsonism. Dr. … laboratory is also utilizing new technologies to identify drug targets for GD and other lysosomal disorders, which may … neurons. This approach promises convenient and less costly therapy for GD, and may have therapeutic utility in PD. … …
News Release
In a new large-scale genetic analysis, National Institutes of Health (NIH) scientists have found set of small RNA molecules, called microRNAs, in human pancreatic cells that are strongly associated with type 2 diabetes.
… the course of the condition or for future development of drug therapies. This study represents the largest …
News Release
NIH researchers have discovered a rare and sometimes lethal inflammatory disease - otulipenia - that primarily affects young children.
News Release
Experts discussed the gaps, challenges and opportunities in genomics at Genomic Medicine Meeting VIII: NHGRI's Genomic Medicine Portfolio, sponsored by NHGRI.
… variant "actionable," that is, when there is a medical therapy that can be applied. "Actionable" might mean … genomics to help predict how a patient will respond to a drug, or pharmacogenomics - will bring about changes to …
Clinical Research
The study collects genetic and medical information from people with GNE myopathy to understand the symptoms and clinical course of GNE myopathy.
… underway. NIH investigators are developing ManNAc  as a therapy for GNE Myopathy. … This study collects genetic and … to Collaborate with National Institutes of Health on Therapy in Late-Stage Development for GNE Myopathy (2018) NIH Launches Trial to Evaluate Drug for Rare Degenerative Muscle Disease Treatment  (2012) …
The Genomics Landscape
In the July 2018 edition of The Genomics Landscape, NHGRI Director Eric Green highlights the 10th anniversary of the Undiagnosed Diseases Program.
… that Viruses May Play a Role in Alzheimer's Disease Novel Drug Therapy Partially Restores Hearing in Mice Notable …